 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pfizer said to be leaving industry trade group BIO...

Pfizer said to be leaving industry trade group BIO

NEW HAVEN, Conn., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...

Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Natera (NTRA Research Report), ImmunoGen (IMGN Research Repor...

Analysts Conflicted on These Healthcare Names: Natera (NTRA), ImmunoGen (IMGN) and Pfizer (PFE)

Overall response rate of 42% and median progression-free survival of 11.1 months in heavily pre-treated patients (after 11 months median follow-up time and based on 48% of events) demonstrates the...

Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE ) and Plans to Expand Vepdegestrant Development Program

Marco Investment Management LLC lessened its holdings in Pfizer Inc. (NYSE:PFE  Free Report) by 5.9% during the 2nd quarter, according to the company in its most recent 13F filing with the...

Pfizer Inc. (NYSE:PFE) Shares Sold by Marco Investment Management LLC

Obesity has been linked to development of a range of diseases and unfortunately, cancer. More specifically, the National Cancer Institute estimated that colorectal cancer is 1.3 times more likely in...

While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer

Pfizer, Valneva complete recruitment for Phase 3 Lyme vaccine study...

Pfizer, Valneva complete recruitment for Phase 3 Lyme vaccine study

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme...

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15

Albert Bourla, chief executive of US pharma giant, accepts IDA Ireland's Special Recognition Award on behalf of the company...

Pfizer hails Ireland as 'industrial powerhouse' in life sciences

Pfizer shares have fallen by double digits this year...

Is Pfizer Stock a Buy Now?

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Market Cap	$162.56B
Volume (M)	9,045.00
52-Wk High	$54.93
52-Wk Low	$28.30

PFE Pfizer Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals